Polycystic ovary syndrome: Prognosis and risk of comorbidity

Novel Insights into the Pathophysiology and Treatment of PCOS

Volumn , Issue , 2013, Pages 123-137

  Hardy, Tristan ^a   De Sousa, Sunita ^b   Norman, Robert J ^b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84957002588     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2217/EBO.12.214     Document Type: Chapter

References (30)

1. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 8, 41 (2010).
2. Boomsma C, Eijkemans M, Hughes E et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum. Reprod. Update 12, 673-683 (2006).
3. Kjerulff LE, Sanchez Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis. Am. J. Obstet. Gynecol. 204(6), 558.e1-6 (2011).
4. Macklon NS. Polycystic ovary syndrome. Br. Med. J. 343, d6407 (2011).
5. Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. Br. Med. J. 343, d6309 (2011).
6. Fauser BC, Tarlatzis BC, Rebar RW et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-sponsored 3rd PCOS Consensus Workshop Group. Fertil. Steril. 97, 28-38 (2012).
7. Jones GL, Hall JM, Balen AH et al. Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review. Hum. Reprod. Update 14, 15-25 (2008).
8. Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: a review. Obstet. Gynecol. Surv. 61, 723-732 (2006).
9. Teede HJ, Misso ML, Deeks AA et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med. J. Aust. 195(6), S65-S112 (2011).
10. Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod. Biomed. Online 19, 398-405 (2009).
11. Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum. Fertil. (Camb.) 3, 101-105 (2003).
12. Glueck CJ, Dharashivkar S, Wang P et al. Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy. Eur. J. Obstet. Gynecol. Reprod. Biol. 122, 206-212.
13. Ching HL, Burke V, Stuckey BG. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin. Endocrinol. (Oxf.) 66, 373-379 (2007).
14. Lord J, Thomas R, Fox B et al. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG 113, 1203-1209 (2006).
15. Carmina E, Chu MC, Longo RA et al. Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J. Clin. Endocrinol. Metab. 90, 2545-2549 (2005).
16. DeUgarte C, Bartolucci C, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil. Steril. 83, 1454-1460 (2005).
17. Moran LJ, Misso ML, Wild RA et al. Impaired glucose tolerance, Type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update 16(4), 347-367 (2010).
18. Ehrmann DA, Kasza K, Azziz R et al. Effects of race and family history of Type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 90, 66-71 (2005).
19. Lo JC, Feigenbaum SL, Yang J et al. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 91, 1357-1363 (2006).
20. Srikanthan P, Korenman S, Davis S. Polycystic ovarian syndrome: the next cardiovascular dilemma in women? Endocrinol. Metab. Clin. N. Am. 35, 611-631 (2006).
21. Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am. J. Med. 111, 607-613 (2001).
22. Vgontzas AN, Legro RS, Bixler EO et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J. Clin. Endocrinol. Metab. 86, 517-520 (2001).
23. Tasali E, Van Cauter E, Ehrmann DA. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 91, 36-42 (2006).
24. Cerda C, Perez-Ayuso RM, Riquelme A et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J. Hepatol. 47, 412-417 (2007).
25. Setji TL, Holland ND, Sanders LL et al. Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 91, 1741-1747 (2006).
26. Toulis KA, Goulis DG, Mintziori G et al. Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome. Hum. Reprod. Update 17, 741-760 (2011).
27. Fauser BC, Bouchard, P. Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age. J. Clin. Endocrinol. Metab. 96(12), 3675-3677 (2011).
28. de Groot PC, Dekkers OM, Romijn JA et al. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum. Reprod. Update 17, 495-500 (2011).
29. Wang ET, Cirillo PM, Vittinghoff E. Menstrual irregularity and cardiovascular mortality. J. Clin. Endocrinol. Metab. 96, E114-E118 (2011).
30. Norman RJ, Dewailly D, Legro R et al. Polycystic ovary syndrome. Lancet 370, 685-697 (2007).